Related references
Note: Only part of the references are listed.Enantiomer-specific pharmacokinetics of D,L-3-hydroxybutyrate: Implications for the treatment of multiple acyl-CoA dehydrogenase deficiency
Willemijn J. van Rijt et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2021)
Divergent trajectories of cellular bioenergetics, intermediary metabolism and systemic redox status in survivors and non-survivors of critical illness
Helen T. McKenna et al.
REDOX BIOLOGY (2021)
Identification of the toxic threshold of 3-hydroxybutyrate-sodium supplementation in septic mice
Ruben Weckx et al.
BMC PHARMACOLOGY & TOXICOLOGY (2021)
A Systematic Review of Intravenous β-Hydroxybutyrate Use in Humans - A Promising Future Therapy?
Hayden White et al.
FRONTIERS IN MEDICINE (2021)
Altered cholesterol homeostasis in critical illness-induced muscle weakness: effect of exogenous 3-hydroxybutyrate
Chloe Goossens et al.
CRITICAL CARE (2021)
Impact of withholding early parenteral nutrition in adult critically ill patients on ketogenesis in relation to outcome
Astrid De Bruyn et al.
CRITICAL CARE (2021)
Effects of β-hydroxybutyrate on cognition in patients with type 2 diabetes
Nicole Jacqueline Jensen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Five-year impact of ICU-acquired neuromuscular complications: a prospective, observational study
Nathalie Van Aerde et al.
INTENSIVE CARE MEDICINE (2020)
ICU-acquired weakness
Ilse Vanhorebeek et al.
INTENSIVE CARE MEDICINE (2020)
Ketone Bodies Attenuate Wasting in Models of Atrophy
Andrew P. Koutnik et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
Beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, attenuates anxiety-related behavior in a rodent post-traumatic stress disorder model
Takehiko Yamanashi et al.
SCIENTIFIC REPORTS (2020)
Effect of withholding early parenteral nutrition in PICU on ketogenesis as potential mediator of its outcome benefit
Astrid De Bruyn et al.
CRITICAL CARE (2020)
Gastrointestinal dysfunction in the critically ill: a systematic scoping review and research agenda proposed by the Section of Metabolism, Endocrinology and Nutrition of the European Society of Intensive Care Medicine
Annika Reintam Blaser et al.
CRITICAL CARE (2020)
Glucose control in the ICU
Jan Gunst et al.
CURRENT OPINION IN ANESTHESIOLOGY (2019)
Ketone ester supplementation blunts overreaching symptoms during endurance training overload
Chiel Poffe et al.
JOURNAL OF PHYSIOLOGY-LONDON (2019)
Hepatic PPARα is critical in the metabolic adaptation to sepsis
Rejane Paumelle et al.
JOURNAL OF HEPATOLOGY (2019)
Safety and tolerability of sustained exogenous ketosis using ketone monoester drinks for 28 days in healthy adults
Adrian Soto-Mota et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2019)
Adipose tissue protects against sepsis-induced muscle weakness in mice: from lipolysis to ketones
Chloe Goossens et al.
CRITICAL CARE (2019)
Context is key: exogenous ketosis and athletic performance
David J. Dearlove et al.
CURRENT OPINION IN PHYSIOLOGY (2019)
Effects of 3-hydroxybutyrate and free fatty acids on muscle protein kinetics and signaling during LPS-induced inflammation in humans: anticatabolic impact of ketone bodies
Henrik H. Thomsen et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2018)
Mechanisms of Organ Dysfunction in Sepsis
Rachel Pool et al.
CRITICAL CARE CLINICS (2018)
ON THE ROLE OF ILLNESS DURATION AND NUTRIENT RESTRICTION IN CHOLESTATIC ALTERATIONS THAT OCCUR DURING CRITICAL ILLNESS
Marc Jenniskens et al.
SHOCK (2018)
A Ketogenic Formula Prevents Tumor Progression and Cancer Cachexia by Attenuating Systemic Inflammation in Colon 26 Tumor-Bearing Mice
Kentaro Nakamura et al.
NUTRIENTS (2018)
Premorbid obesity, but not nutrition, prevents critical illness-induced muscle wasting and weakness
Chloe Goossens et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
On the Metabolism of Exogenous Ketones in Humans
Brianna J. Stubbs et al.
FRONTIERS IN PHYSIOLOGY (2017)
Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness
Sarah Derde et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2017)
The Population Pharmacokinetics of D-β-hydroxybutyrate Following Administration of (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate
Vittal Shivva et al.
AAPS JOURNAL (2016)
Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes
Pete J. Cox et al.
CELL METABOLISM (2016)
Metabolic response to the stress of critical illness
J. -C. Preiser et al.
BRITISH JOURNAL OF ANAESTHESIA (2014)
BHBA Suppresses LPS-Induced Inflammation in BV-2 Cells by Inhibiting NF-κB Activation
Shou-Peng Fu et al.
MEDIATORS OF INFLAMMATION (2014)
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
Surendra K. Shukla et al.
CANCER & METABOLISM (2014)
Impact of Early Parenteral Nutrition on Muscle and Adipose Tissue Compartments During Critical Illness
Michael P. Casaer et al.
CRITICAL CARE MEDICINE (2013)
A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease
Yoshihiro Kashiwaya et al.
NEUROBIOLOGY OF AGING (2013)
Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial
Greet Hermans et al.
LANCET RESPIRATORY MEDICINE (2013)
Oral 28-day and developmental toxicity studies of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate
Kieran Clarke et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2012)
Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects
Kieran Clarke et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2012)
Enantioselective determination of 3-hydroxybutyrate in the tissues of normal and streptozotocin-induced diabetic rats of different ages
Wei-Yu Hsu et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2011)
Skeletal muscle dysfunction in critical care: Wasting, weakness, and rehabilitation strategies
Zudin Puthucheary et al.
CRITICAL CARE MEDICINE (2010)
Stereoselective effects of 3-hydroxybutyrate on glucose utilization of rat cardiomyocytes
YC Tsai et al.
LIFE SCIENCES (2006)
(D)-β-hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G
AKP Taggart et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Identification of L-3-hydroxybutyrate as an original ketone body in rat serum by column-switching high-performance liquid chromatography and fluorescence derivatization
YC Tsai et al.
ANALYTICAL BIOCHEMISTRY (2003)
D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD)
JLK Van Hove et al.
LANCET (2003)
Association between mitochondrial dysfunction and severity and outcome of septic shock
D Brealey et al.
LANCET (2002)
Share Paper
